Diagnosis
NT1 is diagnosed using clinical history together with objective sleep testing—primarily overnight polysomnography (PSG) followed by the Multiple Sleep Latency Test (MSLT)—and/or measurement of cerebrospinal fluid (CSF) orexin‑1 levels.11‑15 Clinicians follow two major diagnostic frameworks: the International Classification of Sleep Disorders, Third Edition (ICSD‑3 / ICSD‑3‑TR) and the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM‑5).11,14,15
ICSD-3/ICSD-3-TR diagnostic criteria for NT1:11
- Daily periods of irrepressible need to sleep or daytime lapses into sleep for ≥3 months
Plus at least ONE of the following (ICSD‑3 Criterion B):
- Cataplexy AND mean sleep latency ≤8 minutes AND ≥2 sleep-onset REM periods (SOREMP) on MSLT; OR one SOREMP on prior nocturnal PSG may substitute for one MSLT SOREMP
- Low CSF orexin-1 (hypocretin-1) levels ≤110 pg/mL OR <1/3 of mean normal values using the same assay
Per the ICSD‑3, NT2 is distinguished from NT1 by the absence of cataplexy, and that CSF hypocretin-1 concentration has not been measured or is either >110 pg/mL or >1/3 of mean values obtained in normal subjects.11
DSM‑5 diagnostic criteria for narcolepsy:14,15
- Recurrent periods of irrepressible need to sleep, lapsing into sleep, or napping within the same day ≥3 times/week for ≥3 months
Plus at least ONE of the following (DSM-5 Criterion B):
- Cataplexy at least a few times per month
- Hypocretin deficiency, defined as ≤1/3 of values obtained in healthy subjects or ≤110 pg/mL
- Nocturnal PSG showing REM sleep latency ≤ 15 minutes OR mean latency on MSLT ≤ 8 minutes + ≥ 2 SOREMPs
Key Note
DSM‑5 does not distinguish NT1 from NT2.
Diagnostic Challenges
- Diagnosis is often delayed. There is wide variability in the time between symptom onset and diagnosis, with a mean diagnostic delay of up to 15 years from symptom onset to correct diagnosis. Many patients are misdiagnosed with other neuropsychiatric or sleep disorders, and up to 50% of patients may be misdiagnosed7,16
- Barriers to accurate diagnosis include:
- Symptom overlap with other disorders (e.g., depression, sleep apnea, Attention-Deficit/Hyperactivity Disorder (ADHD))
- Excessive Daytime Sleepiness (EDS)—often the first symptom to manifest—is associated with a variety of medical conditions17
- Delayed or missed recognition of cataplexy often occurs because its presentation can be subtle or atypical. This challenge is compounded by differences in how clinicians and patients describe cataplexy symptoms, as well as the absence of objective tools to detect and measure cataplexy18,19
- There is low awareness of NT1 among healthcare providers, especially physicians who are not board-certified in sleep medicine. These physicians are less likely to use ICSD criteria-based tests when evaluating patients16
- Masking of NT1 symptoms by medications for comorbid conditions20
- Although narcolepsy often begins in childhood or adolescence, its symptoms present differently in children than in adults, making early recognition challenging21